Assessment of the safety and efficacy of combination chemotherapy and PD-1/PD-L1 inhibitor treatment of breast cancer: A meta-analysis

BACKGROUND: As the efficacy of programmed cell death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors combined with chemotherapy in curing breast cancer is still controversial, this meta-analysis compares the efficacy and safety of PD-1/PD-L1 inhibitors combined with chemotherapy and chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Da, Xu, Yuhao, Wu, Yihao, Qiu, Jie, Hong, Weimin, Meng, Xuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344516/
https://www.ncbi.nlm.nih.gov/pubmed/37279392
http://dx.doi.org/10.1097/CM9.0000000000002631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344516/
https://www.ncbi.nlm.nih.gov/pubmed/37279392
http://dx.doi.org/10.1097/CM9.0000000000002631

Ejemplares similares